Thomas Triomphe - updates

Rappler's latest stories on Thomas Triomphe

ARTICLE FINDER

DOH to sue Sanofi over refusal to give full Dengvaxia refund

Feb 20, 2018 - 10:42 AM

Health Secretary Francisco Duque III and his staff are now in talks with the Office of the Solicitor General to build a case against the maker of the controversial dengue vaccine

GOING AFTER SANOFI. Current DOH Secretary Francisco Duque III sits at a Senate hearing on Dengvaxia beside former health chief Janette Garin, who launched the controversial dengue vaccination program. File photo by Angie de Silva/Rappler

Sanofi Pasteur vows to shoulder expenses of dengue vaccine victims

Jan 22, 2018 - 2:58 PM

Thomas Triomphe, Asia Pacific head of the pharmaceutical giant, says there should be scientific evidence that Dengvaxia indeed caused the death or any other case

Photo by Angie Silva/Rappler

Sanofi agrees to refund P1.4B for unused Dengvaxia vials

Jan 15, 2018 - 1:40 PM

Dengue vaccine maker Sanofi Pasteur hopes its decision to comply will allow it to 'work more openly and constructively with the DOH to address the negative tone' towards Dengvaxia

SANOFI REFUND. A health worker shows off vials of Dengvaxia vaccine inside the storage facility of the DOH on December 4, 2017. Photo by Ben Nabong/Rappler

DOH demands P1.4-B refund from Sanofi over unused Dengvaxia vials

Jan 12, 2018 - 4:05 PM

Health Secretary Francisco Duque III says Sanofi Pasteur’s dengue vaccine is ‘considered defective under Philippine civil laws’

DENGVAXIA FORUM. Health Secretary Francisco Duque III holds an open forum on the Dengvaxia vaccine at the Parang Elementary School in Marikina City on January 11, 2018. Photo from DOH

Sanofi admits Dengvaxia doses imported into PH before contract

Dec 13, 2017 - 9:50 PM

A lawmaker questions why the pharmaceutical company seemed 'certain all along' that it would get the contract from the Philippine government

A health worker shows off used vials of Dengvaxia vaccine inside the storage facility of the local government health sector that was given to students during the school-based immunisation in Manila on December 4, 2017. Photo by Ben Nabong/Rappler

Sanofi exec denies meeting with Aquino a 'sales pitch'

Dec 13, 2017 - 6:35 PM

'We talked about the profile of safety and efficacy of the product after 20 years of [research and development],' says Sanofi Pasteur Asia-Pacific head Thomas Triomphe

COURTESY CALL. Ex-president Benigno Aquino III meets with executives of Dengvaxia vaccine maker Sanofi Pasteur on December 1, 2015. Screenshot from RTVM

Sanofi insists 'no reason for public scare' after dengue vaccine advisory

Dec 13, 2017 - 4:29 PM

Sanofi Pasteur Asia Pacific head Thomas Triomphe tells a House committee there is no worldwide scare due to their latest advisory, and that Dengvaxia is safe and effective

IN THE HOT SEAT. Thomas Triomphe (right), head of Sanofi Pasteur-Asia Pacific, and Ta Wen Yu of Dengvaxia, testify at the House joint committee probe into the Dengvaxia deal at the House of Representatives, December 13, 2017. Photo by Darren Langit/Rappler